Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Maverick BioMetals
AddedFeb 16, 2024
UpdatedJul 3, 2026
Maverick BioMetals

Maverick BioMetals

Series A

Biotech firm Maverick BioMetals innovates in green, efficient lithium extraction.

HQ
San Francisco, CA, US
Founded
2022
Accelerator
Y Combinator logoY CombinatorS22
Overview
Compare
Fundraising
Employees

Maverick BioMetals is a biotechnology company focused on revolutionizing lithium extraction through biological processes. Founded by Eric Herrera and Jesse Evans, the company aims to make lithium production greener, more energy-efficient, and cost-effective. Their proprietary technology targets hard rock deposits, offering a sustainable alternative to traditional mining methods. Maverick BioMetals is actively forming partnerships with mining companies to implement their innovative solutions.

The company has made significant strides in the biotech and mining sectors, showcasing the potential for biology-driven advancements in metal production. By reducing the environmental impact and operational costs associated with lithium extraction, Maverick BioMetals is poised to influence the future of sustainable mining. Their efforts have garnered attention from industry leaders and potential investors, solidifying their position as pioneers in green technology.

Maverick BioMetals - Similar Companies

Maverix Biomics logo

Maverix Biomics

maverixbio.com

Maven Bio logo

Maven Bio

mavenbio.io

Wild Microbes logo

Wild Microbes

wildmicrobes.com

Bluumbio logo

Bluumbio

bluumbio.com

Alga Biosciences logo

Alga Biosciences

alga.bio

Cisterna Biologics logo

Cisterna Biologics

cisternabx.com

MantleBio logo

MantleBio

mantlebio.com

Lygos logo

Lygos

lygos.com

Innovative Genetics logo

Innovative Genetics

LevitasBio logo

LevitasBio

levitasbio.com

Capra Biosciences logo

Capra Biosciences

Mirá Biotech logo

Mirá Biotech

mirabio.co

Windfall Bio logo

Windfall Bio

windfall.bio

Strm.Bio logo

Strm.Bio

strm.bio

Terremoto Biosciences logo

Terremoto Biosciences

terremotobio.com

Maverick BioMetals - Quick Facts

Who are Maverick BioMetals' competitors?

Companies similar to Maverick BioMetals include Maverix Biomics, Maven Bio, Wild Microbes and Bluumbio.

When was Maverick BioMetals founded?

Maverick BioMetals was founded in 2022.

Where is Maverick BioMetals' headquarters located?

Maverick BioMetals' headquarters is located in San Francisco, CA, US.

When was Maverick BioMetals' last funding round?

Maverick BioMetals' most recent funding round was for $9.6M (USD) in January 2024.

How much has Maverick BioMetals raised to-date?

As of Jan 5, 2024, Maverick BioMetals has raised a total of $9.6M (USD).

How many employees does Maverick BioMetals have?

Maverick BioMetals has 8 employees as of Feb 5, 2024.

Maverick BioMetals - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Lithium Extraction
Tags
  • Cleantech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software